You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Pheno and USB reveal neurodegenerative disease programme agreement

Pheno Therapeutics (Pheno)– a company focused on the development of small molecule therapeutics for the treatment of neurological diseases – has announced that it has entered into an exclusive worldwide licence agreement with UCB.